The global oxygen ventilator market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of respiratory diseases and rising awareness about the benefits of oxygen therapy.
Invasive ventilators are used in patients with acute respiratory failure or those who have undergone surgery for lung cancer or other lung disease. Noninvasive ventilators are used in patients with chronic obstructive pulmonary disease (COPD) and asthma, as well as those who have undergone surgery for lung cancer or other lung disease. The invasive ventilator segment is expected to grow at a CAGR of 6% during the forecast period, while the noninvasive segment is expected to grow at a CAGR of 4%.
Some Of The Growth Factors Of This Market:
- The increasing number of patients with chronic respiratory diseases such as COPD and asthma is driving the demand for oxygen ventilators.
- The growing aging population is also a major factor in the growth of this market, as it increases the prevalence of chronic respiratory diseases.
- The rising incidence of lung cancer and other lung-related cancers will also drive the demand for oxygen ventilators in coming years, as these patients are often treated with supplemental oxygen therapy to help them breathe more easily during treatment and recovery periods.
- Increasing awareness about health benefits associated with using an oxygen ventilator will also drive market growth in coming years, as many people are now aware that supplemental oxygen therapy can help improve their quality of life by reducing shortness of breath, fatigue, anxiety and depression symptoms associated with chronic respiratory diseases such as COPD or asthma.
- Technological advancements in this field will also fuel market growth over the next few years due to increased availability of portable devices that can be used at home or on-the-go without requiring a power source or bulky equipment.
Industry Growth Insights published a new data on “Oxygen Ventilator Market”. The research report is titled “Oxygen Ventilator Market research by Types (Invasive Ventilator, Noninvasive Ventilator), By Applications (Hospital and Clinic), By Players/Companies Koninklijke Philips, Omron Healthcare, Merck, Cipla, GlaxoSmithKline, PARI Medical Holding, Teva Pharmaceutical Industries, AstraZeneca, Beximco Pharmaceuticals, Market Segment by Product Type, Dry Powder Inhaler, Metered Dose Inhaler, Market Segment by Application, Hospital and Clinic”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxygen Ventilator Market Research Report
By Type
Invasive Ventilator, Noninvasive Ventilator
By Application
Hospital and Clinic
By Companies
Koninklijke Philips, Omron Healthcare, Merck, Cipla, GlaxoSmithKline, PARI Medical Holding, Teva Pharmaceutical Industries, AstraZeneca, Beximco Pharmaceuticals, Market Segment by Product Type, Dry Powder Inhaler, Metered Dose Inhaler, Market Segment by Application, Hospital and Clinic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Oxygen Ventilator Market Report Segments:
The global Oxygen Ventilator market is segmented on the basis of:
Types
Invasive Ventilator, Noninvasive Ventilator
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital and Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Koninklijke Philips
- Omron Healthcare
- Merck
- Cipla
- GlaxoSmithKline
- PARI Medical Holding
- Teva Pharmaceutical Industries
- AstraZeneca
- Beximco Pharmaceuticals
- Market Segment by Product Type
- Dry Powder Inhaler
- Metered Dose Inhaler
- Market Segment by Application
- Hospital and Clinic
Highlights of The Oxygen Ventilator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Invasive Ventilator
- Noninvasive Ventilator
- By Application:
- Hospital and Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxygen Ventilator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An oxygen ventilator is a machine that helps people with breathing problems breathe more easily. It uses a special type of air to help the person breathe better.
Some of the major players in the oxygen ventilator market are Koninklijke Philips, Omron Healthcare, Merck, Cipla, GlaxoSmithKline, PARI Medical Holding, Teva Pharmaceutical Industries, AstraZeneca, Beximco Pharmaceuticals, Market Segment by Product Type, Dry Powder Inhaler, Metered Dose Inhaler, Market Segment by Application, Hospital and Clinic.
The oxygen ventilator market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxygen Ventilator Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oxygen Ventilator Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oxygen Ventilator Market - Supply Chain
4.5. Global Oxygen Ventilator Market Forecast
4.5.1. Oxygen Ventilator Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oxygen Ventilator Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oxygen Ventilator Market Absolute $ Opportunity
5. Global Oxygen Ventilator Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oxygen Ventilator Market Size and Volume Forecast by Type
5.3.1. Invasive Ventilator
5.3.2. Noninvasive Ventilator
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oxygen Ventilator Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oxygen Ventilator Market Size and Volume Forecast by Application
6.3.1. Hospital and Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oxygen Ventilator Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oxygen Ventilator Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oxygen Ventilator Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oxygen Ventilator Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oxygen Ventilator Demand Share Forecast, 2019-2026
9. North America Oxygen Ventilator Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oxygen Ventilator Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oxygen Ventilator Market Size and Volume Forecast by Application
9.4.1. Hospital and Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oxygen Ventilator Market Size and Volume Forecast by Type
9.7.1. Invasive Ventilator
9.7.2. Noninvasive Ventilator
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oxygen Ventilator Demand Share Forecast, 2019-2026
10. Latin America Oxygen Ventilator Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oxygen Ventilator Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oxygen Ventilator Market Size and Volume Forecast by Application
10.4.1. Hospital and Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oxygen Ventilator Market Size and Volume Forecast by Type
10.7.1. Invasive Ventilator
10.7.2. Noninvasive Ventilator
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oxygen Ventilator Demand Share Forecast, 2019-2026
11. Europe Oxygen Ventilator Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oxygen Ventilator Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oxygen Ventilator Market Size and Volume Forecast by Application
11.4.1. Hospital and Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oxygen Ventilator Market Size and Volume Forecast by Type
11.7.1. Invasive Ventilator
11.7.2. Noninvasive Ventilator
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oxygen Ventilator Demand Share, 2019-2026
12. Asia Pacific Oxygen Ventilator Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oxygen Ventilator Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oxygen Ventilator Market Size and Volume Forecast by Application
12.4.1. Hospital and Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oxygen Ventilator Market Size and Volume Forecast by Type
12.7.1. Invasive Ventilator
12.7.2. Noninvasive Ventilator
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oxygen Ventilator Demand Share, 2019-2026
13. Middle East & Africa Oxygen Ventilator Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oxygen Ventilator Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oxygen Ventilator Market Size and Volume Forecast by Application
13.4.1. Hospital and Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oxygen Ventilator Market Size and Volume Forecast by Type
13.7.1. Invasive Ventilator
13.7.2. Noninvasive Ventilator
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oxygen Ventilator Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oxygen Ventilator Market: Market Share Analysis
14.2. Oxygen Ventilator Distributors and Customers
14.3. Oxygen Ventilator Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Koninklijke Philips
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Omron Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cipla
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GlaxoSmithKline
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PARI Medical Holding
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva Pharmaceutical Industries
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. AstraZeneca
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Beximco Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Market Segment by Product Type
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Dry Powder Inhaler
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Metered Dose Inhaler
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Market Segment by Application
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Hospital and Clinic
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
